Horan Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.52M | Sell |
39,214
-29
| -0.1% | -$2.71K | 1.19% | 28 |
|
|
2024
Q4 | $3.9M | Sell |
39,243
-891
| -2% | -$91.9K | 1.31% | 22 |
|
|
2024
Q3 | $4.56M | Sell |
40,134
-119
| -0.3% | -$14.1K | 1.51% | 18 |
|
|
2024
Q2 | $4.98M | Sell |
40,253
-201
| -0.5% | -$25.9K | 1.75% | 15 |
|
|
2024
Q1 | $5.34M | Buy |
40,454
+382
| +1% | +$47.1K | 1.9% | 14 |
|
|
2023
Q4 | $4.37M | Sell |
40,072
-775
| -2% | -$80.4K | 1.6% | 15 |
|
|
2023
Q3 | $4.21M | Buy |
40,847
+2,191
| +6% | +$236K | 1.69% | 15 |
|
|
2023
Q2 | $4.46M | Buy |
38,656
+85
| +0.2% | +$9.65K | 1.74% | 14 |
|
|
2023
Q1 | $4.1M | Sell |
38,571
-29
| -0.1% | -$3.13K | 1.69% | 17 |
|
|
2022
Q4 | $4.28M | Sell |
38,600
-430
| -1% | -$44K | 1.88% | 11 |
|
|
2022
Q3 | $3.36M | Buy |
39,030
+595
| +2% | +$53.1K | 1.63% | 20 |
|
|
2022
Q2 | $3.5M | Buy |
38,435
+246
| +0.6% | +$21.8K | 1.63% | 17 |
|
|
2022
Q1 | $3.13M | Buy |
38,189
+1,033
| +3% | +$81.4K | 1.26% | 32 |
|
|
2021
Q4 | $2.85M | Sell |
37,156
-52
| -0.1% | -$4.14K | 1.13% | 35 |
|
|
2021
Q3 | $2.79M | Buy |
37,208
+600
| +2% | +$45.6K | 1.24% | 34 |
|
|
2021
Q2 | $2.85M | Buy |
36,608
+414
| +1% | +$30.8K | 1.28% | 32 |
|
|
2021
Q1 | $2.66M | Buy |
36,194
+865
| +2% | +$63.8K | 1.28% | 30 |
|
|
2020
Q4 | $2.76M | Buy |
35,329
+2,121
| +6% | +$162K | 1.43% | 25 |
|
|
2020
Q3 | $2.63M | Buy |
33,208
+470
| +1% | +$36.8K | 1.49% | 21 |
|
|
2020
Q2 | $2.42M | Sell |
32,738
-446
| -1% | -$33.6K | 1.62% | 20 |
|
|
2020
Q1 | $2.44M | Buy |
33,184
+1,126
| +4% | +$88.5K | 1.95% | 16 |
|
|
2019
Q4 | $2.78M | Sell |
32,058
-730
| -2% | -$60K | 1.65% | 19 |
|
|
2019
Q3 | $2.63M | Sell |
32,788
-419
| -1% | -$33.6K | 1.61% | 19 |
|
|
2019
Q2 | $2.66M | Sell |
33,207
-1,404
| -4% | -$108K | 1.79% | 16 |
|
|
2019
Q1 | $2.75M | Sell |
34,611
-3,347
| -9% | -$250K | 1.74% | 20 |
|
|
2018
Q4 | $2.77M | Buy |
37,958
+367
| +1% | +$25.9K | 1.85% | 17 |
|
|
2018
Q3 | $2.54M | Sell |
37,591
-438
| -1% | -$27.9K | 1.64% | 26 |
|
|
2018
Q2 | $2.2M | Buy |
+38,029
| New | +$2.15M | 1.41% | 33 |
|
|
2017
Q4 | – | Sell |
-3,385
| Closed | -$207K | – | 193 |
|
|
2017
Q3 | $207K | Sell |
3,385
-996
| -23% | -$60.4K | 0.13% | 71 |
|
|
2017
Q2 | $268K | Sell |
4,381
-71
| -2% | -$4.32K | 0.18% | 63 |
|
|
2017
Q1 | $270K | Buy |
4,452
+405
| +10% | +$24.6K | 0.19% | 58 |
|
|
2016
Q4 | $227K | Hold |
4,047
| – | – | 0.17% | 59 |
|
|
2016
Q3 | $241K | Buy |
+4,047
| New | +$237K | 0.19% | 54 |
|
|
2014
Q3 | – | Sell |
-5,133
| Closed | -$283K | – | 63 |
|
|
2014
Q2 | $283K | Buy |
5,133
+94
| +2% | +$5.13K | 0.26% | 61 |
|
|
2014
Q1 | $273K | Sell |
5,039
-1,572
| -24% | -$81.4K | 0.26% | 63 |
|
|
2013
Q4 | $316K | Buy |
6,611
+542
| +9% | +$24.8K | 0.32% | 58 |
|
|
2013
Q3 | $276K | Buy |
+6,069
| New | +$277K | 0.33% | 58 |
|
Other funds holding MRK
Horan Capital Advisors's MRK Position: Q1 2025 in Review
Horan Capital Advisors reduced its Merck (MRK) stake by 0.07% in Q1 2025, selling an estimated $2.71K and leaving 39,214 shares worth $3.52M. The position accounts for 1.19% of the portfolio, ranked #28.
Horan Capital Advisors first reported a position in MRK in Q3 2013 and has held it in 37 quarters since. The position peaked at $5.34M in Q1 2024. 3,449 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Horan Capital Advisors held 39,214 shares of Merck worth $3.52M as of Q1 2025.
- Horan Capital Advisors sold 29 Merck shares in Q1 2025, an estimated $2.71K.
- Merck made up 1.19% of Horan Capital Advisors's portfolio in Q1 2025, its #28 holding.
- Horan Capital Advisors first reported a position in Merck in Q3 2013 and has held it in 37 quarters since.
- Horan Capital Advisors's Merck position peaked at $5.34M in Q1 2024.
- 3,449 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Horan Capital Advisors's 13F filing for Q1 2025, filed 7 May 2025.